Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.41 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.41 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.41 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4975665 | 0.97 | HSP90AA1 (0.46) | MEN1KMT2ACNR1CNR2L3MBTL1 | |
| SCHEMBL3980745 | 0.94 | NPC1 (0.44) | MEN1KMT2AL3MBTL1POLBPLAAT3 | |
| SCHEMBL4979942 | 0.85 | MGLL (0.38) | MEN1KMT2ARAB9ANAMPT | |
| SCHEMBL3977113 | 0.84 | MGLL (0.42) | MEN1KMT2ACNR2RAB9ANAMPT | |
| SCHEMBL3982025 | 0.84 | MGLL (0.42) | MEN1KMT2ACNR2RAB9ANAMPT | |
| SCHEMBL4979475 | 0.84 | MGLL (0.42) | MEN1KMT2ACNR2RAB9ANAMPT | |
| SCHEMBL4984400 | 0.84 | MGLL (0.42) | MEN1KMT2ACNR2RAB9ANAMPT | |
| SCHEMBL4980970 | 0.83 | KDM4E (0.46) | L3MBTL1 | |
| SCHEMBL4979173 | 0.82 | NAMPT (0.40) | L3MBTL1RAB9ANAMPT | |
| SCHEMBL4980961 | 0.82 | LMNA (0.42) | KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096875-A1 | THIOUREA COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096875-A1 | THIOUREA COMPOUNDS | TPMT, HAVCR2, ETV6 | MEN1 2494/4885KMT2A 1846/4885CNR1 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.